Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort study.
Karin HellgrenChristine BallegaardBénédicte DelcoigneRene Lindholm CordtzDan NordströmKalle AaltonenBjorn GudbjornssonThorvardur Jon LoveSella Aarrestad ProvanJoe SextonKristian ZobbeLars Erik KristensenJohan AsklingLene DreyerPublished in: Rheumatology (Oxford, England) (2021)
In this large cohort study from five Nordic countries, we found no increased risk of solid cancer in TNFi-treated PsA patients, neither for solid cancer overall nor for eight common cancer types.